Expression of the tachykinin receptor mRNAs in healthy human colon

European Journal of Pharmacology

Volumn 599, Issue 1-3, 2008, Pages 121-125

  Jaafari, Nadia ^a,b   Hua, Guoqiang ^b,c,d   Adélaïde, José ^b,c,d   Julé, Yvon ^a   Imbert, Jean ^b,c,d  

^a Biovays   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Healthy human colon; mRNA; Tachykinin receptor; TACR1; TACR2; TACR3

Indexed keywords

MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; TACHYKININ RECEPTOR;

ADULT; ARTICLE; COLON; FEMALE; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; COLON; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 55049094487     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.09.024     Document Type: Article

References (38)

1. Almeida T.A., Rojo J., Nieto P.M., Pinto F.M., Hernandez M., Martin J.D., and Candenas M.L. Tachykinins and tachykinin receptors: structure and activity relationships. Curr. Med. Chem. 11 (2004) 2045-2081
2. Appleyard C.B., Morales M., and Santiago C. Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon. Dig. Dis. Sci. 53 (2008) 220-228
3. Baker S.J., Morris J.L., and Gibbins I.L. Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system. Brain Res. Mol. Brain Res. 111 (2003) 136-147
4. Bellucci F., Meini S., Catalioto R.M., Catalani C., Giuliani S., Quartara L., Giolitti A., Faiella A., Rotondaro L., Candenas M.L., Pinto F.M., and Maggi C.A. Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells. Eur. J. Pharmacol. 499 (2004) 229-238
5. Boutaghou-Cherid H., Porcher C., Liberge M., Jule Y., Bunnett N.W., and Christen M.O. Expression of the neurokinin type 1 receptor in the human colon. Auton. Neurosci. 124 (2006) 9-17
6. Caberlotto L., Hurd Y.L., Murdock P., Wahlin J.P., Melotto S., Corsi M., and Carletti R. Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur. J. Neurosci. 17 (2003) 1736-1746
7. Candenas M.L., Cintado C.G., Pennefather J.N., Pereda M.T., Loizaga J.M., Maggi C.A., and Pinto F.M. Identification of a tachykinin NK(2) receptor splice variant and its expression in human and rat tissues. Life Sci. 72 (2002) 269-277
8. Dery O., Defea K.A., and Bunnett N.W. Protein kinase C-mediated desensitization of the neurokinin 1 receptor. Am. J. Physiol. Cell Physiol. 280 (2001) C1097-C1106
9. Dheda K., Huggett J.F., Bustin S.A., Johnson M.A., Rook G., and Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37 (2004) 112-119
10. Fong T.M., Anderson S.A., Yu H., Huang R.R., and Strader C.D. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. 41 (1992) 24-30
11. Furness J.B., and Sanger G.J. Intrinsic nerve circuits of the gastrointestinal tract: identification of drug targets. Curr. Opin. Pharmacol. 2 (2002) 612-622
12. Gerard N.P., Eddy Jr. R.L., Shows T.B., and Gerard C. The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues. J. Biol. Chem. 265 (1990) 20455-20462
13. Goode T., O'Connell J., Ho W.Z., O'Sullivan G.C., Collins J.K., Douglas S.D., and Shanahan F. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells. Clin. Diagn. Lab. Immunol. 7 (2000) 371-376
14. Holzer P. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Digestion 59 (1998) 269-283
15. Holzer P. Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur. J. Pharmacol. 429 (2001) 177-193
16. Holzer P., and Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol. Ther. 73 (1997) 173-217
17. Holzer P., and Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol. Ther. 73 (1997) 219-263
18. Houghton L.A., Cremonini F., Camilleri M., Busciglio I., Fell C., Cox V., Alpers D.H., Dewit O.E., Dukes G.E., Gray E., Lea R., Zinsmeister A.R., and Whorwell P.J. Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol. Motil. 19 (2007) 732-743
19. Jaafari N., Khomitch-Baud A., Christen M.O., and Jule Y. Distribution pattern of tachykinin NK2 receptors in human colon: involvement in the regulation of intestinal motility. J. Comp. Neurol. 503 (2007) 381-391
20. Lecci A., Capriati A., and Maggi C.A. Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Br. J. Pharmacol. 141 (2004) 1249-1263
21. Lecci A., Capriati A., Altamura M., and Maggi C.A. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human. Auton. Neurosci. 126-127 (2006) 232-249
22. Li H., Leeman S.E., Slack B.E., Hauser G., Saltsman W.S., Krause J.E., Blusztajn J.K., and Boyd N.D. A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization. Proc. Natl. Acad. Sci. U.S.A 94 (1997) 9475-9480
23. Liu L., Shang F., Markus I., and Burcher E. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease. J. Pharmacol. Exp. Ther. 302 (2002) 627-635
24. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
25. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. 26 (1995) 911-944
26. Mantyh P.W., Mantyh C.R., Gates T., Vigna S.R., and Maggio J.E. Receptor binding sites for substance P and substance K in the canine gastrointestinal tract and their possible role in inflammatory bowel disease. Neuroscience 25 (1988) 817-837
27. Mantyh C.R., Vigna S.R., Bollinger R.R., Mantyh P.W., Maggio J.E., and Pappas T.N. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 109 (1995) 850-860
28. Massi M., Panocka I., and de C.G. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides 21 (2000) 1597-1609
29. Page N.M. Hemokinins and endokinins. Cell. Mol. Life Sci. 61 (2004) 1652-1663
30. Page N.M. New challenges in the study of the mammalian tachykinins. Peptides 26 (2005) 1356-1368
31. Page N.M., and Bell N.J. The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal. Eur. J. Pharmacol. 437 (2002) 27-30
32. Patacchini R., and Maggi C.A. Peripheral tachykinin receptors as targets for new drugs. Eur. J. Pharmacol. 429 (2001) 13-21
33. Pinto F.M., Almeida T.A., Hernandez M., Devillier P., Advenier C., and Candenas M.L. mRNA expression of tachykinins and tachykinin receptors in different human tissues. Eur. J. Pharmacol. 494 (2004) 233-239
34. Renzi D., Pellegrini B., Tonelli F., Surrenti C., and Calabro A. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am. J. Pathol. 157 (2000) 1511-1522
35. Sasai Y., and Nakanishi S. Molecular characterization of rat substance K receptor and its mRNAs. Biochem. Biophys. Res. Commun. 165 (1989) 695-702
36. Shimizu Y., Matsuyama H., Shiina T., Takewaki T., and Furness J.B. Tachykinins and their functions in the gastrointestinal tract. Cell. Mol. Life Sci. 65 (2008) 295-311
37. Weidenhofer J., Yip J., Zavitsanou K., Huang X.F., Chahl L.A., and Tooney P.A. Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary investigation in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1313-1321
38. Yokota Y., Sasai Y., Tanaka K., Fujiwara T., Tsuchida K., Shigemoto R., Kakizuka A., Ohkubo H., and Nakanishi S. Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 264 (1989) 17649-17652